Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018

Objective. To determine the magnitude of mortality due to acute lymphoblastic leukemia (ALL) nationally and by age group, sex, state of residence and insurance status, as well as to evaluate time trends during the period 1998-2018 Materials and methods. We obtained ALL mortality data and estimated a...

Full description

Bibliographic Details
Main Authors: Paloma Muñoz-Aguirre, Marta Zapata-Tarrés, Priscilla Espinosa-Tamez, Hugo Sánchez-Blas, Marion Brochier, Héctor Lamadrid-Figueroa
Format: Article
Language:English
Published: Instituto Nacional de Salud Pública 2022-02-01
Series:Salud Pública de México
Subjects:
Online Access:https://www.saludpublica.mx/index.php/spm/article/view/13210
_version_ 1798000569815662592
author Paloma Muñoz-Aguirre
Marta Zapata-Tarrés
Priscilla Espinosa-Tamez
Hugo Sánchez-Blas
Marion Brochier
Héctor Lamadrid-Figueroa
author_facet Paloma Muñoz-Aguirre
Marta Zapata-Tarrés
Priscilla Espinosa-Tamez
Hugo Sánchez-Blas
Marion Brochier
Héctor Lamadrid-Figueroa
author_sort Paloma Muñoz-Aguirre
collection DOAJ
description Objective. To determine the magnitude of mortality due to acute lymphoblastic leukemia (ALL) nationally and by age group, sex, state of residence and insurance status, as well as to evaluate time trends during the period 1998-2018 Materials and methods. We obtained ALL mortality data and estimated age-standardized national, state-level and health insurance mortality rates. We conducted a joinpoint regression analysis to describe mortality trends across the study period and estimate the average annual percent change (AAPC). Results. In a 20-year period, age-standardized ALL mortality rates increased from 1.6 per 100 000 in 1998 to 1.7 in 2018. Nationally, a constant annual increase in mortality was observed for both sexes (1998-2002 AAPC 0.6 in boys, and 1998-2002 AAPC 0.3 in girls). We observed heteroge­neity in childhood ALL at a state level. Conclusion. Our results reflect the social, economic, geographic diversity of the country. Monitoring and surveillance of this disease is crucial to assess quality of care.
first_indexed 2024-04-11T11:22:25Z
format Article
id doaj.art-299371340d3b40a3b7bfaa52eb1dedc6
institution Directory Open Access Journal
issn 0036-3634
language English
last_indexed 2024-04-11T11:22:25Z
publishDate 2022-02-01
publisher Instituto Nacional de Salud Pública
record_format Article
series Salud Pública de México
spelling doaj.art-299371340d3b40a3b7bfaa52eb1dedc62022-12-22T04:26:32ZengInstituto Nacional de Salud PúblicaSalud Pública de México0036-36342022-02-01641263410.21149/1321012095Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018Paloma Muñoz-Aguirre0Marta Zapata-Tarrés1Priscilla Espinosa-Tamez2Hugo Sánchez-Blas3Marion Brochier4Héctor Lamadrid-Figueroa5Consejo Nacional de Ciencia y Tecnología. Mexico City, Mexico/Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MexicoCoordinación de Investigación, Fundación IMSS, A.C. Mexico City, MexicoUCSF Helen Diller Family Comprehensive Cancer Center, University of California. San Francisco, United StatesCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MexicoCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MexicoCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MexicoObjective. To determine the magnitude of mortality due to acute lymphoblastic leukemia (ALL) nationally and by age group, sex, state of residence and insurance status, as well as to evaluate time trends during the period 1998-2018 Materials and methods. We obtained ALL mortality data and estimated age-standardized national, state-level and health insurance mortality rates. We conducted a joinpoint regression analysis to describe mortality trends across the study period and estimate the average annual percent change (AAPC). Results. In a 20-year period, age-standardized ALL mortality rates increased from 1.6 per 100 000 in 1998 to 1.7 in 2018. Nationally, a constant annual increase in mortality was observed for both sexes (1998-2002 AAPC 0.6 in boys, and 1998-2002 AAPC 0.3 in girls). We observed heteroge­neity in childhood ALL at a state level. Conclusion. Our results reflect the social, economic, geographic diversity of the country. Monitoring and surveillance of this disease is crucial to assess quality of care.https://www.saludpublica.mx/index.php/spm/article/view/13210mortalitychildhood cancerallleukemiamexicopediatric cancer
spellingShingle Paloma Muñoz-Aguirre
Marta Zapata-Tarrés
Priscilla Espinosa-Tamez
Hugo Sánchez-Blas
Marion Brochier
Héctor Lamadrid-Figueroa
Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018
Salud Pública de México
mortality
childhood cancer
all
leukemia
mexico
pediatric cancer
title Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018
title_full Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018
title_fullStr Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018
title_full_unstemmed Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018
title_short Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018
title_sort childhood acute lymphoblastic leukemia in mexico mortality trend analysis 1998 2018
topic mortality
childhood cancer
all
leukemia
mexico
pediatric cancer
url https://www.saludpublica.mx/index.php/spm/article/view/13210
work_keys_str_mv AT palomamunozaguirre childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018
AT martazapatatarres childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018
AT priscillaespinosatamez childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018
AT hugosanchezblas childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018
AT marionbrochier childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018
AT hectorlamadridfigueroa childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018